Ignite Creation Date:
2025-12-24 @ 12:45 PM
Ignite Modification Date:
2026-01-10 @ 1:35 PM
Study NCT ID:
NCT03117361
Status:
TERMINATED
Last Update Posted:
2020-12-02
First Post:
2017-04-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide
Sponsor:
PharmaMar
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
APL-B-022-15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None